heart palpitations and semaglutide & Rate: What You Should Know Are you noticing your heart

The Obesity Cohort Produced One of the Strongest Signals Among patients with breast cancer and obesity, GLP-1 receptor agonist use was associated with a substantially lower hazard of all-cause mortality compared with nonuse

Both online doctors and endocrinologists generally recommend ongoing treatment with periodic evaluation of continued need and effectiveness

In the peptide therapy context, AbbVie's Lupron (leuprolide) franchise treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty via GnRH agonism remains a stable legacy contributor, while Botox Therapeutic ($748 million in Q1 2024 alone) constitutes a significant peptide-adjacent revenue stream

Semaglutide went back in at 3 mg with weekly checks

MDD has been linked to a decline in monoaminergic neurotransmitters, such as noradrenaline, dopamine, and serotonin

It is not medical advice or a substitute for the advice of a physician